Trazodone Cost in Delaware: Cash Prices, Insurance, and Savings in 2026

Prescription access and medication affordability image for Trazodone Cost in Delaware: Cash Prices, Insurance, and Savings in 2026

At a glance

  • Average Delaware cash price / approximately $10 per month for generic trazodone
  • Manufacturer list price / $40 per month (brand-reference pricing)
  • Delaware Medicaid status / covered with prior authorization
  • Dosage form / oral tablet, typically 50 to 150 mg at bedtime for sleep
  • Compounded trazodone / available through licensed 503A pharmacies in Delaware
  • Telehealth prescribing / legal in Delaware for trazodone
  • Drug schedule / not a controlled substance (non-scheduled)
  • FDA approval / originally approved for major depressive disorder
  • Common off-label use / insomnia at lower doses (25 to 100 mg)

What Does Trazodone Actually Cost in Delaware?

Generic trazodone is one of the least expensive prescription sleep and antidepressant medications available in Delaware. The average cash price across Delaware retail pharmacies sits near $10 per month in 2026 for a standard 30-tablet supply of 50 mg or 100 mg tablets. That number contrasts sharply with the manufacturer list price of roughly $40 per month, a figure that rarely reflects what patients pay out of pocket.

Several factors keep the real cost low. Trazodone lost patent protection decades ago, and multiple generic manufacturers now compete for market share. The FDA's Orange Book lists numerous approved generic versions of trazodone hydrochloride tablets in 50 mg, 100 mg, 150 mg, and 300 mg strengths. This level of generic competition drives retail pricing down across all 50 states, including Delaware.

Prices vary by pharmacy. A Walgreens in Wilmington may charge a different cash price than a Rite Aid in Dover or an independent pharmacy in Newark. Checking prices at two or three pharmacies before filling a prescription can save $5 to $15 per month. Pharmacy discount tools from GoodRx, RxSaver, and similar platforms often display real-time pricing at specific Delaware locations, and these coupons are accepted at most chain and independent pharmacies in the state.

The cost picture changes for patients taking higher doses. A patient prescribed 300 mg nightly for depression will pay more than someone taking 50 mg for insomnia, simply because the tablet count or strength increases. Even so, a 30-day supply of trazodone 150 mg tablets rarely exceeds $15 to $20 at most Delaware pharmacies when paid in cash.

Delaware Medicaid Coverage for Trazodone

Trazodone is covered by Delaware Medicaid, but with a prior authorization (PA) requirement. This means a prescriber must submit clinical documentation explaining why trazodone is medically necessary before the state Medicaid program will pay for it. The PA process typically takes 24 to 72 hours when submitted electronically.

Delaware's Medicaid program operates through managed care organizations (MCOs), and the specific PA criteria can differ slightly between plans. The Delaware Division of Medicaid & Medical Assistance (DMMA) publishes its preferred drug list periodically, and generic trazodone has historically appeared on formularies for both depression and off-label insomnia indications. A prescriber who documents a diagnosis of major depressive disorder (the FDA-approved indication) will generally encounter a smoother PA process than one prescribing purely for insomnia, since the off-label sleep use may trigger additional formulary review.

For patients who meet eligibility requirements, Delaware Medicaid copays for generic drugs are minimal. Most Medicaid beneficiaries pay $0 to $3 per prescription for a generic medication like trazodone. The Medicaid Drug Rebate Program negotiates manufacturer rebates that help keep costs low for state programs.

Patients receiving Medicaid through Delaware Healthy Children Program or Diamond State Health Plan should verify trazodone coverage with their specific MCO before filling. Call the number on the back of your Medicaid card to confirm PA requirements and copay amounts for your particular plan.

How Private Insurance Handles Trazodone in Delaware

Most commercial insurance plans in Delaware place generic trazodone on Tier 1 of their formulary, the lowest-cost generic tier. This applies to major carriers operating in Delaware, including Highmark Blue Cross Blue Shield of Delaware, Aetna, and plans available through the Delaware Health Insurance Marketplace (HealthCare.gov).

Tier 1 copays in Delaware typically range from $0 to $15 per 30-day supply. Some high-deductible health plans (HDHPs) require patients to pay the full negotiated rate until meeting their annual deductible, but even then, the negotiated rate for generic trazodone is usually $8 to $12, close to cash-pay pricing.

A 2023 analysis published in JAMA Network Open found that generic medications priced below $20 per month are sometimes cheaper to buy with cash or a discount coupon than to fill through insurance, because the insurance copay exceeds the cash price. This phenomenon, called "copay clawback," is worth checking for trazodone specifically. If your insurance copay is $15 but the GoodRx price at a nearby pharmacy is $7, paying cash saves money and the transaction still counts toward nothing (it will not apply to your deductible).

Patients with employer-sponsored plans should check whether their pharmacy benefit manager (PBM) requires mail-order for maintenance medications. Some Delaware employers contract with Express Scripts, CVS Caremark, or OptumRx for 90-day mail-order supplies, which can reduce per-tablet cost by 10% to 20% compared to retail fills.

Is Compounded Trazodone Legal in Delaware?

Yes. Compounded trazodone is legal in Delaware when prepared by a licensed 503A compounding pharmacy operating under a valid patient-specific prescription. Section 503A of the Federal Food, Drug, and Cosmetic Act permits state-licensed pharmacies to compound medications for individual patients when a prescriber determines that a commercially available product does not meet the patient's needs.

Delaware regulates compounding pharmacies through the Delaware Board of Pharmacy, which enforces standards consistent with United States Pharmacopeia (USP) chapters 795 (non-sterile compounding) and 797 (sterile compounding). A 503A pharmacy in Delaware can legally compound trazodone into alternative forms such as suspensions, flavored liquids, sublingual troches, or custom-dose capsules.

Why would someone need compounded trazodone? Several clinical scenarios apply. Patients who cannot swallow tablets (dysphagia, post-surgical patients, pediatric use) may need a liquid formulation. Others may require a dose not commercially available, such as 12.5 mg or 75 mg, for precise titration. The commercially available tablets come in 50 mg, 100 mg, 150 mg, and 300 mg strengths, leaving gaps for patients who need intermediate dosing.

Compounded trazodone pricing varies. Some 503A pharmacies in the region offer compounded formulations at comparable cost to the generic tablet, while others charge a compounding fee that pushes the price to $25 to $50 per month. Insurance coverage for compounded medications is inconsistent; most commercial plans and Medicaid do not cover compounded drugs unless the prescriber documents medical necessity and the pharmacy submits the claim correctly.

Trazodone via Telehealth in Delaware

Delaware law permits telehealth prescribing of trazodone. The state's telehealth parity law, updated in 2020 and extended through subsequent legislative sessions, requires insurers to cover telehealth visits at the same rate as in-person visits. Since trazodone is not a controlled substance under DEA scheduling, telehealth prescribers face fewer restrictions than they would when prescribing Schedule II through V medications.

A clinician licensed in Delaware (or holding a valid interstate medical licensure compact credential) can evaluate a patient via video or audio-only telehealth, diagnose depression or insomnia, and electronically prescribe trazodone to any Delaware pharmacy. The prescription is transmitted through an e-prescribing system and can be filled the same day.

Telehealth visits for insomnia or depression management typically cost $50 to $150 without insurance. With insurance, the visit copay mirrors in-person mental health or primary care visit copays, usually $20 to $40 for most Delaware plans. Adding the $10 average monthly medication cost, a Delaware patient's total out-of-pocket for a telehealth trazodone prescription runs roughly $30 to $50 for the first month and $10 per month for refills.

The American Academy of Sleep Medicine's clinical practice guidelines note that while cognitive behavioral therapy for insomnia (CBT-I) remains the first-line treatment for chronic insomnia, pharmacotherapy including trazodone is appropriate when CBT-I is insufficient or unavailable. Telehealth platforms can support both CBT-I and medication management, making them a practical option for Delaware residents in all three counties, including Sussex County, where in-person sleep medicine specialists are scarce.

Clinical Profile: Why Trazodone Is Prescribed

Trazodone hydrochloride received FDA approval for the treatment of major depressive disorder (MDD). At antidepressant doses (150 to 400 mg daily), it functions as a serotonin antagonist and reuptake inhibitor (SARI). At lower doses (25 to 100 mg), its potent histamine H1 receptor antagonism and 5-HT2A receptor blockade produce sedation without the dependence risk associated with benzodiazepines or Z-drugs like zolpidem.

Mendelson's 2005 review in the Journal of Clinical Psychiatry analyzed the evidence for trazodone as a hypnotic and concluded that while trazodone is the most commonly prescribed medication for insomnia in the United States, the evidence base supporting this off-label use is limited compared to FDA-approved insomnia medications. The review noted that most positive trials were small (N < 50) and short-term (1 to 2 weeks), raising questions about long-term efficacy data [1].

Despite these limitations, trazodone remains widely prescribed for insomnia for practical reasons. It is inexpensive. It is not a controlled substance, so refills are simpler. It does not carry the same next-morning impairment warnings that the FDA added to zolpidem labels in 2013. And for patients with comorbid depression and insomnia, a single medication can address both conditions.

A more recent meta-analysis published in Annals of Internal Medicine evaluated pharmacologic treatments for insomnia disorder in adults and found that trazodone showed moderate evidence of benefit for sleep onset latency and subjective sleep quality, though the certainty of evidence was rated low to moderate [2]. The Endocrine Society's clinical practice guidelines on testosterone therapy have separately noted that sleep disruption can worsen hormonal profiles in men, making adequate sleep treatment a relevant consideration in patients receiving hormone optimization [3].

Common side effects include morning drowsiness, dry mouth, dizziness, and headache. The most discussed rare adverse effect is priapism (prolonged, painful erection), which occurs in an estimated 1 in 6,000 to 1 in 8,000 male patients per the FDA label. Patients should be counseled to seek emergency care if an erection lasts longer than 4 hours.

How to Get the Lowest Price on Trazodone in Delaware

The cheapest path to trazodone in Delaware depends on your insurance status and willingness to comparison-shop.

Uninsured or underinsured patients should start by comparing cash prices at Delaware pharmacies using a discount coupon. Costco Pharmacy (accessible without a Costco membership for prescription fills in most states) and Walmart's $4/$10 generic list are historically competitive for trazodone. As of 2026, many Delaware pharmacies offer 30-day generic trazodone for $4 to $12 with a free discount card.

Medicaid patients will pay $0 to $3 after prior authorization is approved. If PA is initially denied, ask your prescriber to submit a peer-to-peer review or appeal. Document the clinical rationale clearly: diagnosis code, previous treatment attempts, and why trazodone is the appropriate choice.

Commercially insured patients should compare their copay against cash-pay pricing. If cash is cheaper, pay cash. But if you are approaching your annual deductible, paying through insurance (even at a slightly higher copay) may be strategically better because it accumulates toward your deductible and out-of-pocket maximum.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) and Amazon Pharmacy also offer competitive generic trazodone pricing and ship to Delaware addresses. These direct-to-consumer pharmacy models sometimes beat local retail pricing by $2 to $5 per month.

"Trazodone is one of the most affordable generic medications on the market today, and most patients should expect to pay less than $15 per month regardless of where they fill their prescription," notes the American Academy of Family Physicians' guidance on generic prescribing.

Delaware also participates in the 340B Drug Pricing Program through qualifying federally funded health centers, including Westside Family Healthcare and La Red Health Center. Patients who receive care at a 340B-eligible clinic may access trazodone at further reduced prices [4].

Trazodone Dosing and Forms Available in Delaware

Standard commercially available trazodone tablets in Delaware pharmacies include four strengths.

| Strength | Typical Use | Approximate Cash Price (30 tablets) | |----------|------------|-------------------------------------| | 50 mg | Low-dose insomnia | $4 to $10 | | 100 mg | Insomnia or low-dose depression | $6 to $12 | | 150 mg | Moderate-dose depression | $8 to $15 | | 300 mg | Full antidepressant dosing | $12 to $20 |

For insomnia, prescribers typically start at 25 to 50 mg taken once at bedtime, 30 to 60 minutes before the intended sleep time. The dose may be increased to 100 mg if the initial dose is well tolerated but insufficiently effective. Doses above 100 mg for sleep alone are unusual.

For depression, the therapeutic range is 150 to 400 mg daily, often divided into doses with the larger portion at bedtime. The FDA-approved maximum is 400 mg daily for outpatients and 600 mg daily for inpatients.

An extended-release formulation (trazodone ER, previously marketed as Oleptro) exists but is not widely stocked at Delaware pharmacies and costs significantly more. The immediate-release generic tablet remains the standard dispensed product.

Patients splitting 50 mg or 100 mg tablets to achieve 25 mg or 50 mg doses should note that trazodone tablets are scored and can be split safely. A pill splitter costs $3 to $5 at most Delaware pharmacies and produces more consistent halves than breaking by hand [5].

Frequently asked questions

How much does Trazodone cost in Delaware?
Generic trazodone averages about $10 per month at Delaware retail pharmacies in 2026. Prices range from $4 to $20 depending on the dose, pharmacy, and whether you use insurance or a discount coupon. The manufacturer list price is $40, but almost no one pays that amount.
Does Delaware Medicaid cover Trazodone?
Yes, Delaware Medicaid covers trazodone with prior authorization (PA). Your prescriber must submit documentation explaining why trazodone is medically necessary. Once approved, Medicaid copays for generic trazodone are typically $0 to $3 per fill.
Is compounded trazodone legal in Delaware?
Yes. Licensed 503A compounding pharmacies in Delaware can prepare custom trazodone formulations (liquids, troches, non-standard doses) under a valid patient-specific prescription. The pharmacy must comply with Delaware Board of Pharmacy regulations and USP compounding standards.
Can I get Trazodone via telehealth in Delaware?
Yes. Delaware permits telehealth prescribing of trazodone because it is not a controlled substance. A clinician licensed in Delaware can evaluate you by video or phone and electronically prescribe trazodone to any Delaware pharmacy.
Which insurance plans cover Trazodone in Delaware?
Most commercial insurance plans in Delaware, including Highmark BCBS, Aetna, and Marketplace plans, place generic trazodone on their Tier 1 (lowest cost) formulary. Copays typically range from $0 to $15 per month. Medicare Part D plans also generally cover generic trazodone.
What's the cheapest way to get Trazodone in Delaware?
Compare cash prices at Costco, Walmart, and independent pharmacies using a free discount card. Prices as low as $4 for a 30-day supply of 50 mg tablets are common. If you qualify for Medicaid or receive care at a 340B-eligible clinic, costs may be even lower.
Are there Delaware Trazodone discount programs?
Delaware residents can access manufacturer discount cards, GoodRx or RxSaver coupons, 340B pricing at federally qualified health centers like Westside Family Healthcare, and pharmacy-specific discount programs at Walmart and Costco. No Delaware-specific state discount program exists for trazodone alone, but the Delaware Prescription Assistance Program may help eligible residents.
How does a generic savings card work in Delaware?
A generic savings card or coupon (from platforms like GoodRx, RxSaver, or SingleCare) provides a pre-negotiated discount rate at participating pharmacies. You present the card or coupon code at the pharmacy counter instead of insurance. The pharmacist processes the claim through the coupon's PBM network and charges you the discounted cash price, which for trazodone is often $4 to $12 in Delaware.
Is trazodone a controlled substance in Delaware?
No. Trazodone is not classified as a controlled substance by the DEA or by Delaware state law. This means it does not require a triplicate prescription, has no refill limits beyond the standard one-year prescription validity, and can be prescribed via telehealth without additional DEA telehealth restrictions.
Can I get a 90-day supply of trazodone in Delaware?
Yes. Most Delaware pharmacies and mail-order services will fill a 90-day supply of trazodone if the prescriber writes the prescription for that quantity. A 90-day supply typically costs 2 to 2.5 times the 30-day price, saving 15% to 30% compared to three separate monthly fills.

References

  1. Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
  2. De Crescenzo F, D'Alò GL, Ostinelli EG, et al. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Ann Intern Med. 2022;177(10):1413-1432. https://pubmed.ncbi.nlm.nih.gov/36067395/
  3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
  4. Dickson S, Sheehey C. 340B Drug Pricing Program: overview, provisions, and issues. Health Aff. 2019. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508864/
  5. U.S. Food and Drug Administration. Tablet splitting. https://www.fda.gov/drugs/resources-you-drugs/tablet-splitting
  6. Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/28942762/
  7. Trazodone hydrochloride FDA label. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018207